Clinical Trial: An Extension Clinical Study of BCD-148 for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria Previously Treated in Clinical Study No. BCD-148-2/NOCTURN

U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06987864) titled 'An Extension Clinical Study of BCD-148 for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria Previously Treated in Clinical Study No. BCD-148-2/NOCTURN' on May 16.

Brief Summary: To study the long-term safety and efficacy of BCD-148 in patients with paroxysmal nocturnal hemoglobinuria (PNH), previously treated in clinical study (CS) BCD-148-2/NOCTURN

Study Start Date: April 13, 2020

Study Type: INTERVENTIONAL

Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)

Intervention: BIOLOGICAL: eculizumab

Intravenous infusion of BCD-148 every 2 weeks

Recruitment Status: COMPLETED

Sponsor: Biocad

Disclaimer: Curated...